Neurocognitive Impairment among HIV-Infected Participants on Methadone for IV-Heroin use in Yunnan, China Relates to AIDS Status and Depression Severity, not Patterns of Substance use

Avery Matthews; Jennifer E Iudicello; Ni Sun-Suslow; Crystal X Wang; Chuan Shi; Scott Letendre; Jianhua Li; Patricia K Riggs; Donald R Franklin Jr; Hua Jin; J Hampton Atkinson; Xin Yu; Zunyou Wu; Igor Grant; Robert K Heaton*; The HNRC Group

Avery Matthews, Jennifer E Iudicello, Ni Sun-Suslow, Crystal X Wang, Chuan Shi, Scott Letendre, Jianhua Li, Patricia K Riggs, Donald R Franklin Jr, Hua Jin, J Hampton Atkinson, Xin Yu, Zunyou Wu, Igor Grant, Robert K Heaton* and The HNRC Group

Volume5-Issue6
Dates: Received: 2024-06-04 | Accepted: 2024-06-10 | Published: 2024-06-11
Pages: 549-561

Abstract

We used a comprehensive and culturally normed battery of Neurocognitive (NC) tests to evaluate NC impairment (NCI) in 406 adults with prior IV heroin use who were in a government-supervised methadone maintenance program in Yunnan province, China. Participants included 202 without HIV infection, 57 with AIDS, and 147 HIV+ without AIDS (“nonAIDS group”). The AIDS group had higher proportions of individuals with global NCI (38.6%) relative to nonAIDS (15.7%) and HIV- participants (17.3%; ps < 0.01). The AIDS group performed worse than the non AIDS group globally (< 0.001), and in the domains of executive functioning (ps = 0.001), learning (ps = 0.035), and speeded information processing (ps = 0.0002). Despite the lack of difference in prevalence of NCI between non AIDS and HIV- groups, the non AIDS group showed impairment in memory and complex motor domains relative to the HIV- group (p = 0.03). In People With HIV (PWH), NCI was associated with more severe depression symptoms and HIV disease characteristics (duration of illness, CD4 nadir, AIDS status). Nearly all participants were HCV infected. Alcohol use disorder diagnoses, non-invasive indications of liver fibrosis, and characteristics of prior heroin use were not associated with NCI. PWH with NCI had worse daily functioning, as indexed by unemployment (ps = 0.016) and reported increased cognitive difficulties in daily life (ps = 0.016). These results highlight the importance of early HIV diagnosis and treatment to avoid HIV disease progression, particularly among IV drug users, with the goal of protecting NC abilities, everyday functioning, and life quality in infected individuals.

FullText HTML FullText PDF DOI: 10.37871/jbres1925

Certificate of Publication

Copyright

How to cite this article

Matthews A, Iudicello JE, Sun-Suslow N, Wang CX, Shi C, Letendre S, Li J, Riggs PK, Franklin Jr DR, Jin H, Atkinson JH, Yu X, Wu Z, Grant I, Heaton RK, The HNRC Group. Neurocognitive Impairment among HIV-Infected Participants on Methadone for IV-Heroin use in Yunnan, China Relates to AIDS Status and Depression Severity, not Patterns of Substance use. J Biomed Res Environ Sci. 2024 Jun 11; 5(6): 549-561. doi: 10.37871/jbres1925, Article ID: JBRES1925, Available at: https://www.jelsciences.com/articles/ jbres1925.pdf

Subject area(s)

Mental Health

Public Health

Neurological Disorders

References

Wu Z, Rou K, Cui H. The HIV/AIDS epidemic in China: history, current strategies and future challenges. AIDS Educ Prev. 2004 Jun;16(3 Suppl A):7-17. doi: 10.1521/aeap.16.3.5.7.35521. PMID: 15262561.
Wu Z, Chen J, Scott SR, McGoogan JM. History of the HIV Epidemic in China. Curr HIV/AIDS Rep. 2019 Dec;16(6):458-466. doi: 10.1007/s11904-019-00471-4. PMID: 31773405; PMCID: PMC7088640.
Qian HZ, Schumacher JE, Chen HT, Ruan YH. Injection drug use and HIV/AIDS in China: review of current situation, prevention and policy implications. Harm Reduct J. 2006 Feb 1;3:4. doi: 10.1186/1477-7517-3-4. PMID: 16451717; PMCID: PMC1402269.
Qian HZ, Vermund SH, Kaslow RA, Coffey CS, Chamot E, Yang Z, Qiao X, Zhang Y, Shi X, Jiang Y, Shao Y, Wang N. Co-infection with HIV and hepatitis C virus in former plasma/blood donors: challenge for patient care in rural China. AIDS. 2006 Jun 26;20(10):1429-35. doi: 10.1097/01.aids.0000233577.33973.fa. PMID: 16791018; PMCID: PMC2749723.
UNAIDS. 2021 UNAIDS Global AIDS Update- Confronting inequalities- Lessons for pandemic responses from 40 years of AIDS.
Byrd DA, Robinson-Papp J, Mindt MR, Mintz L, Elliott K, Lighty Q, Morgello S; Manhattan HIV Brain Bank. Isolating cognitive and neurologic HIV effects in substance-dependent, confounded cohorts: a pilot study. J Int Neuropsychol Soc. 2013 Apr;19(4):463-73. doi: 10.1017/S1355617712001634. Epub 2013 Feb 28. PMID: 23446056; PMCID: PMC3815532.
Heaton RK, Clifford DB, Franklin DR Jr, Woods SP, Ake C, Vaida F, Ellis RJ, Letendre SL, Marcotte TD, Atkinson JH, Rivera-Mindt M, Vigil OR, Taylor MJ, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, McCutchan JA, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I; CHARTER Group. HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology. 2010 Dec 7;75(23):2087-96. doi: 10.1212/WNL.0b013e318200d727. PMID: 21135382; PMCID: PMC2995535.
Robertson KR, Hall CD. Assessment of neuroAIDS in the international setting. J Neuroimmune Pharmacol. 2007 Mar;2(1):105-11. doi: 10.1007/s11481-006-9052-0. Epub 2007 Jan 3. PMID: 18040833.
Robertson KR, Smurzynski M, Parsons TD, Wu K, Bosch RJ, Wu J, McArthur JC, Collier AC, Evans SR, Ellis RJ. The prevalence and incidence of neurocognitive impairment in the HAART era. AIDS. 2007 Sep 12;21(14):1915-21. doi: 10.1097/QAD.0b013e32828e4e27. PMID: 17721099.
Reger M, Welsh R, Razani J, Martin DJ, Boone KB. A meta-analysis of the neuropsychological sequelae of HIV infection. J Int Neuropsychol Soc. 2002 Mar;8(3):410-24. doi: 10.1017/s1355617702813212. PMID: 11939699.
Tozzi V, Balestra P, Serraino D, Bellagamba R, Corpolongo A, Piselli P, Lorenzini P, Visco-Comandini U, Vlassi C, Quartuccio ME, Giulianelli M, Noto P, Galgani S, Ippolito G, Antinori A, Narciso P. Neurocognitive impairment and survival in a cohort of HIV-infected patients treated with HAART. AIDS Res Hum Retroviruses. 2005 Aug;21(8):706-13. doi: 10.1089/aid.2005.21.706. PMID: 16131310.
Heaton RK, Marcotte TD, Mindt MR, Sadek J, Moore DJ, Bentley H, McCutchan JA, Reicks C, Grant I; HNRC Group. The impact of HIV-associated neuropsychological impairment on everyday functioning. J Int Neuropsychol Soc. 2004 May;10(3):317-31. doi: 10.1017/S1355617704102130. PMID: 15147590.
Woods SP, Weber E, Weisz BM, Twamley EW, Grant I; HIV Neurobehavioral Research Programs Group. Prospective memory deficits are associated with unemployment in persons living with HIV infection. Rehabil Psychol. 2011 Feb;56(1):77-84. doi: 10.1037/a0022753. PMID: 21401289; PMCID: PMC3264430.
Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Durvasula RS, Lam MN, Stefaniak M. Medication adherence in HIV-infected adults: effect of patient age, cognitive status, and substance abuse. AIDS. 2004 Jan 1;18 Suppl 1(Suppl 1):S19-25. doi: 10.1097/00002030-200418001-00004. PMID: 15075494; PMCID: PMC2886736.
Woods SP, Iudicello JE, Morgan EE, Cameron MV, Doyle KL, Smith TV, Cushman C; HIV Neurobehavioral Research Program (HNRP) Group. Health-Related Everyday Functioning in the Internet Age: HIV-Associated Neurocognitive Disorders Disrupt Online Pharmacy and Health Chart Navigation Skills. Arch Clin Neuropsychol. 2016 Mar;31(2):176-85. doi: 10.1093/arclin/acv090. Epub 2016 Jan 6. PMID: 26743327; PMCID: PMC4758381.
Tozzi V, Balestra P, Murri R, Galgani S, Bellagamba R, Narciso P, Antinori A, Giulianelli M, Tosi G, Fantoni M, Sampaolesi A, Noto P, Ippolito G, Wu AW. Neurocognitive impairment influences quality of life in HIV-infected patients receiving HAART. Int J STD AIDS. 2004 Apr;15(4):254-9. doi: 10.1258/095646204773557794. PMID: 15075020.
Heaton RK, Cysique LA, Jin H, Shi C, Yu X, Letendre S, Franklin DR, Ake C, Vigil O, Atkinson JH, Marcotte TD, Grant I, Wu Z; San Diego HIV Neurobehavioral Research Center Group. Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China. J Neurovirol. 2008 Nov;14(6):536-49. doi: 10.1080/13550280802378880. Erratum in: J Neurovirol. 2010 Mar;16(2):185-8. doi: 10.3109/13550284.2010.481820. PMID: 18991068; PMCID: PMC2889205.
Zhang Y, Qiao L, Ding W, Wei F, Zhao Q, Wang X, Shi Y, Li N, Smith D, Chen D. An initial screening for HIV-associated neurocognitive disorders of HIV-1 infected patients in China. J Neurovirol. 2012 Apr;18(2):120-6. doi: 10.1007/s13365-012-0089-y. Epub 2012 Mar 13. PMID: 22411002; PMCID: PMC3859527.
Bao YP, Liu ZM. Systematic review of HIV and HCV infection among drug users in China. Int J STD AIDS. 2009 Jun;20(6):399-405. doi: 10.1258/ijsa.2008.008362. PMID: 19451325.
Huang MB, Ye L, Liang BY, Ning CY, Roth WW, Jiang JJ, Huang JG, Zhou B, Zang N, Powell MD, Liang H, Bond VC. Characterizing the HIV/AIDS Epidemic in the United States and China. Int J Environ Res Public Health. 2015 Dec 22;13(1):ijerph13010030. doi: 10.3390/ijerph13010030. PMID: 26703667; PMCID: PMC4730421.
Baldacchino A, Balfour DJ, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neurosci Biobehav Rev. 2012 Oct;36(9):2056-68. doi: 10.1016/j.neubiorev.2012.06.006. Epub 2012 Jul 6. PMID: 22771335.
Gruber SA, Silveri MM, Yurgelun-Todd DA. Neuropsychological consequences of opiate use. Neuropsychol Rev. 2007 Sep;17(3):299-315. doi: 10.1007/s11065-007-9041-y. Epub 2007 Aug 10. PMID: 17690984.
Gupta S, Iudicello JE, Shi C, Letendre S, Knight A, Li J, Riggs PK, Franklin DR Jr, Duarte N, Jin H, Hampton Atkinson J, Yu X, Wu Z, Grant I, Heaton RK; HNRC China Collaboration Group. Absence of neurocognitive impairment in a large Chinese sample of HCV-infected injection drug users receiving methadone treatment. Drug Alcohol Depend. 2014 Apr 1;137:29-35. doi: 10.1016/j.drugalcdep.2013.12.021. Epub 2014 Jan 13. PMID: 24508003; PMCID: PMC3961522.
Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, Yurgelun-Todd DA. Methadone maintenance improves cognitive performance after two months of treatment. Exp Clin Psychopharmacol. 2006 May;14(2):157-64. doi: 10.1037/1064-1297.14.2.157. PMID: 16756419.
Applebaum AJ, Otto MW, Richardson MA, Safren SA. Contributors to neuropsychological impairment in HIV-infected and HIV-uninfected opiate-dependent patients. J Clin Exp Neuropsychol. 2010 Jul;32(6):579-89. doi: 10.1080/13803390903313572. Epub 2010 Nov 4. PMID: 19890760; PMCID: PMC3638786.
Weber E, Blackstone K, Woods SP. Cognitive neurorehabilitation of HIV-associated neurocognitive disorders: a qualitative review and call to action. Neuropsychol Rev. 2013 Mar;23(1):81-98. doi: 10.1007/s11065-013-9225-6. Epub 2013 Feb 16. PMID: 23417497; PMCID: PMC3606924.
Kessler RC, Ustün TB. The World Mental Health (WMH) Survey Initiative Version of the World Health Organization (WHO) Composite International Diagnostic Interview (CIDI). Int J Methods Psychiatr Res. 2004;13(2):93-121. doi: 10.1002/mpr.168. PMID: 15297906; PMCID: PMC6878592.
Beck AT, Steer RA, Brown GK. Beck depression inventory-II. The Psychological Corporation; 1996.
Cao W, Hsieh E, Li T. Optimizing Treatment for Adults with HIV/AIDS in China: Successes over Two Decades and Remaining Challenges. Curr HIV/AIDS Rep. 2020 Feb;17(1):26-34. doi: 10.1007/s11904-019-00478-x. PMID: 31939111; PMCID: PMC6989417.
Hestad KA, Menon JA, Silalukey-Ngoma M, Franklin DR Jr, Imasiku ML, Kalima K, Heaton RK. Sex differences in neuropsychological performance as an effect of human immunodeficiency virus infection: a pilot study in Zambia, Africa. J Nerv Ment Dis. 2012 Apr;200(4):336-42. doi: 10.1097/NMD.0b013e31824cc225. PMID: 22456588; PMCID: PMC3886829.
Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK. HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol. 2010 Jul 13;10:60. doi: 10.1186/1471-2377-10-60. PMID: 20626870; PMCID: PMC2912842.
Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK; HNRC Group. Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol. 2004 May;26(3):307-19. doi: 10.1080/13803390490510031. PMID: 15512922.
Cysique LA, Jin H, Franklin DR Jr, Morgan EE, Shi C, Yu X, Wu Z, Taylor MJ, Marcotte TD, Letendre S, Ake C, Grant I, Heaton RK; HNRC Group. Neurobehavioral effects of HIV-1 infection in China and the United States: a pilot study. J Int Neuropsychol Soc. 2007 Sep;13(5):781-90. doi: 10.1017/S1355617707071007. PMID: 17697409; PMCID: PMC2857379.
Cysique LA, Letendre SL, Ake C, Jin H, Franklin DR, Gupta S, Shi C, Yu X, Wu Z, Abramson IS, Grant I, Heaton RK; HIV Neurobehavioral Research Center group. Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS. 2010 Apr 24;24(7):983-90. doi: 10.1097/QAD.0b013e32833336c8. PMID: 20299964; PMCID: PMC2898923.
Hsieh SL, Tori CD. Normative data on cross-cultural neuropsychological tests obtained from Mandarin-speaking adults across the life span. Arch Clin Neuropsychol. 2007 Mar;22(3):283-96. doi: 10.1016/j.acn.2007.01.004. Epub 2007 Feb 12. PMID: 17293080.
Halstead WC. The brain and intelligence: A quantitative study of the frontal lobes. University of Chicago Press; 1947.
Stroop JR. Studies of interference in serial verbal reactions. Journal of Experimental Psychology.1935;18:643-662. doi: 10.1037/h0054651.
Strauss E, Sherman EMS, Spreen O. A compendium of neuropsychological tests: Administration, norms, and commentary. 3rded. Oxford University Press; 2006.
Diehr MC, Heaton RK, Miller W, Grant I. The Paced Auditory Serial Addition Task (PASAT): norms for age, education, and ethnicity. Assessment. 1998 Dec;5(4):375-87. doi: 10.1177/107319119800500407. Erratum in: Assessment 1999 Mar;6(1):101. PMID: 9835661.
Gronwall D, Sampson H. The psychological effects of concussion. Aukland University Press/Oxford University Press; 1974. doi: 10.1192/S000712500010443X.
Wechsler D. Wechsler memory scale-third edition. San Antonio, TX: The Psychological Corporation; 1997. doi: 10.1037/t49755-000.
Benedict RH, Schretlen D, Groninger L, Brandt J. Hopkins verbal learning test–revised: Normative data and analysis of inter-form and test-retest reliability. The Clinical Neuropsychologist. 1998;12:43-55. doi: 10.1076/clin.12.1.43.1726.
Benedict RH, Schretlen D, Groninger L, Dobraski M, Shpritz B. Revision of the brief visuospatial memory test: Studies of normal performance, reliability, and validity. Psychological assessment. 1996;8:145. doi: 10.1037/1040-3590.8.2.145
Wechsler D. WAIS-III administration and scoring manual. San Antonio, TX: The Psychological Corporation; 1997.
Klove H. Clinical Neuropsychology. Med Clin North Am. 1963 Nov;47:1647-58. PMID: 14078168.
Blackstone K, Moore DJ, Franklin DR, Clifford DB, Collier AC, Marra CM, Gelman BB, McArthur JC, Morgello S, Simpson DM, Ellis RJ, Atkinson JH, Grant I, Heaton RK. Defining neurocognitive impairment in HIV: deficit scores versus clinical ratings. Clin Neuropsychol. 2012;26(6):894-908. doi: 10.1080/13854046.2012.694479. Epub 2012 Jun 18. PMID: 22708483; PMCID: PMC3848322.
Chelune GJ, Heaton RK, Lehman RA. Advances in clinical neuropsychology. Springer. 1986;95-126. doi: 10.1007/978-1-4613-2211-5.
Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 1969 Autumn;9(3):179-86. PMID: 5349366.
Paolillo EW, Pasipanodya EC, Moore RC, Pence BW, Atkinson JH, Grelotti DJ, Grant I, Heaton RK, Moore DJ. Cumulative Burden of Depression and Neurocognitive Decline Among Persons With HIV: A Longitudinal Study. J Acquir Immune Defic Syndr. 2020 Jul 1;84(3):304-312. doi: 10.1097/QAI.0000000000002346. PMID: 32195746; PMCID: PMC8725609.
Rubin LH, Maki PM. HIV, Depression, and Cognitive Impairment in the Era of Effective Antiretroviral Therapy. Curr HIV/AIDS Rep. 2019 Feb;16(1):82-95. doi: 10.1007/s11904-019-00421-0. PMID: 30661180; PMCID: PMC6420829.
Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors. J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82. doi: 10.1097/QAI.0b013e318042e1ee. PMID: 17356465.
Letendre S. Central nervous system complications in HIV disease: HIV-associated neurocognitive disorder. Top Antivir Med. 2011 Nov;19(4):137-42. PMID: 22156215; PMCID: PMC4666587.
Cysique LA, Casaletto KB, Heaton RK. Reliably Measuring Cognitive Change in the Era of Chronic HIV Infection and Chronic HIV-Associated Neurocognitive Disorders. Curr Top Behav Neurosci. 2021;50:271-298. doi: 10.1007/7854_2019_116. PMID: 31559600.
Hinkin CH, Hardy DJ, Mason KI, Castellon SA, Lam MN, Stefaniak M, Zolnikov B. Verbal and spatial working memory performance among HIV-infected adults. J Int Neuropsychol Soc. 2002 May;8(4):532-8. doi: 10.1017/s1355617702814278. PMID: 12030306.
Ettenhofer ML, Hinkin CH, Castellon SA, Durvasula R, Ullman J, Lam M, Myers H, Wright MJ, Foley J. Aging, neurocognition, and medication adherence in HIV infection. Am J Geriatr Psychiatry. 2009 Apr;17(4):281-90. doi: 10.1097/JGP.0b013e31819431bd. PMID: 19307857; PMCID: PMC2679810.
He N. Research Progress in the Epidemiology of HIV/AIDS in China. China CDC Wkly. 2021 Nov 26;3(48):1022-1030. doi: 10.46234/ccdcw2021.249. PMID: 34888119; PMCID: PMC8633551.
Hilsabeck RC, Perry W, Hassanein TI. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology. 2002 Feb;35(2):440-6. doi: 10.1053/jhep.2002.31257. PMID: 11826421.